These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917 [TBL] [Abstract][Full Text] [Related]
7. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression. Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319 [TBL] [Abstract][Full Text] [Related]
8. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275 [TBL] [Abstract][Full Text] [Related]
9. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis. Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M Front Immunol; 2018; 9():244. PubMed ID: 29651286 [TBL] [Abstract][Full Text] [Related]
10. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses. Pollara J; Bonsignori M; Moody MA; Pazgier M; Haynes BF; Ferrari G Curr HIV Res; 2013 Jul; 11(5):378-87. PubMed ID: 24191939 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. Ahmad A; Morisset R; Thomas R; Menezes J J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983 [TBL] [Abstract][Full Text] [Related]
12. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis. Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201 [TBL] [Abstract][Full Text] [Related]
13. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Broliden PA; von Gegerfelt A; Clapham P; Rosen J; Fenyö EM; Wahren B; Broliden K Proc Natl Acad Sci U S A; 1992 Jan; 89(2):461-5. PubMed ID: 1370580 [TBL] [Abstract][Full Text] [Related]
14. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals. Ahmad A; Menezes J J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258 [TBL] [Abstract][Full Text] [Related]
16. The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner. Tudor D; Bomsel M AIDS; 2011 Mar; 25(6):751-9. PubMed ID: 21330910 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535 [TBL] [Abstract][Full Text] [Related]
18. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393 [TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. Ferrari G; Place CA; Ahearne PM; Nigida SM; Arthur LO; Bolognesi DP; Weinhold KJ J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):325-31. PubMed ID: 8133445 [TBL] [Abstract][Full Text] [Related]
20. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. Neurath AR; Strick N; Lee ES J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]